NCP07: A potent ERα CBS-targeted degrader with dual-action against ESR1 mutations in breast cancer.
- DOI
- 10.1016/j.ejmech.2026.119113
- Published
- 2026 Nov 5
- Container
- European journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2026.119113,
title = {NCP07: A potent ERα CBS-targeted degrader with dual-action against ESR1 mutations in breast cancer.},
author = {Liang J and Wu Y and Yang L and Xu B and Wang D and Shu HB and Dong C and Li S and Zhou HB},
year = {2026},
journal = {European journal of medicinal chemistry},
doi = {10.1016/j.ejmech.2026.119113},
url = {https://doi.org/10.1016/j.ejmech.2026.119113}
}RIS
TY - JOUR TI - NCP07: A potent ERα CBS-targeted degrader with dual-action against ESR1 mutations in breast cancer. AU - Liang J AU - Wu Y AU - Yang L AU - Xu B AU - Wang D AU - Shu HB AU - Dong C AU - Li S AU - Zhou HB PY - 2026 JO - European journal of medicinal chemistry DO - 10.1016/j.ejmech.2026.119113 UR - https://doi.org/10.1016/j.ejmech.2026.119113 ER -
APA
J, L., Y, W., L, Y., B, X., D, W., HB, S., C, D., S, L., & HB, Z. (2026). NCP07: A potent ERα CBS-targeted degrader with dual-action against ESR1 mutations in breast cancer.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2026.119113
Source records
- pubmed · retrieved 2026-09-27T14:34:38.281Z